Inflammatory bowel disease: a review of pre-clinical murine models of human disease

B Katsandegwaza, W Horsnell, K Smith - International Journal of …, 2022 - mdpi.com
Crohn's disease (CD) and ulcerative colitis (UC) are both highly inflammatory diseases of
the gastrointestinal tract, collectively known as inflammatory bowel disease (IBD). Although …

Dietary polyphenol impact on gut health and microbiota

MLY Wan, VA Co, H El-Nezami - Critical reviews in food science …, 2021 - Taylor & Francis
Polyphenols are naturally occurring compounds in plants and they are the most abundant
antioxidants in the human diet. Due to their considerable structural diversity, this largely …

Design of diselenide-bridged hyaluronic acid nano-antioxidant for efficient ROS scavenging to relieve colitis

J Xu, T Chu, T Yu, N Li, C Wang, C Li, Y Zhang… - Acs Nano, 2022 - ACS Publications
Overproduction of reactive oxygen species (ROS), a key characteristic of inflammatory bowel
disease (IBD), is responsible for dysregulation of signal transduction, inflammatory …

Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway

R Singh, S Chandrashekharappa, SR Bodduluri… - Nature …, 2019 - nature.com
The importance of gut microbiota in human health and pathophysiology is undisputable.
Despite the abundance of metagenomics data, the functional dynamics of gut microbiota in …

The dual role of neutrophils in inflammatory bowel diseases

O Wéra, P Lancellotti, C Oury - Journal of clinical medicine, 2016 - mdpi.com
Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are
characterised by aberrant immunological responses leading to chronic inflammation without …

From flies to men: ROS and the NADPH oxidase in phagocytes

ZM Moghadam, P Henneke, J Kolter - Frontiers in cell and …, 2021 - frontiersin.org
The cellular formation of reactive oxygen species (ROS) represents an evolutionary ancient
antimicrobial defense system against microorganisms. The NADPH oxidases (NOX), which …

[HTML][HTML] Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease

NG Kotla, R Singh, BV Baby, S Rasala, J Rasool… - Biomaterials, 2022 - Elsevier
Delivering drugs directly to the inflamed intestinal sites to treat inflammatory bowel disease
(IBD), particularly Crohn's and ulcerative colitis, is highly challenging. Recent advances in …

[HTML][HTML] Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models

RP do Nascimento, AP da Fonseca Machado, J Galvez… - Life sciences, 2020 - Elsevier
Ulcerative colitis (UC) is an inflammatory bowel disease with increasing incidence in the
world, especially in developing countries. Although knowledge of its pathogenesis has …

Therapeutic potential of amino acids in inflammatory bowel disease

Y Liu, X Wang, CAA Hu - Nutrients, 2017 - mdpi.com
Inflammatory bowel disease (IBD), which includes both ulcerative colitis and Crohn's
disease, is a chronic relapsing inflammation of the gastrointestinal tract, and is difficult to …

Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein Claudin-7

Y Xiao, H Lian, XS Zhong… - Frontiers in …, 2022 - frontiersin.org
Background Previous studies implicated matrix metalloproteinases (MMPs), such as MMP-7,
in inflammatory bowel diseases (IBD) by showing increased activity during inflammation of …